FDA Approves Roche's Influenza Treatment for Use in Young Children - PharmTech

Retrieved on: 2022-08-12 17:59:25

Tags for this article:

Click the tags to see associated articles and topics

FDA Approves Roche's Influenza Treatment for Use in Young Children - PharmTech. View article details on hiswai:

Excerpt

Roche announced that FDA has approved Roche's Xofluza (baloxavir marboxil) to treat influenza in children aged five years and older.

Article found on: www.pharmtech.com